Cargando…
The antitumor activity of CYB-L10, a human topoisomerase IB catalytic inhibitor
DNA topoisomerase IB (TOP1) is a validated target for discovery and development of antitumor agents. Four TOP1 poisons are clinically used for tumor treatment now. In spite of their effectiveness in solid tumors, these camptothecin (CPT) poisons suffer from many shortcomings. Therefore, many investi...
Autores principales: | Yu, Qian, Chen, Yu, Yang, Hui, Zhang, Hong-Li, Agama, Keli, Pommier, Yves, An, Lin-Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442119/ https://www.ncbi.nlm.nih.gov/pubmed/30907213 http://dx.doi.org/10.1080/14756366.2018.1516651 |
Ejemplares similares
-
Optimization of the Lactam
Side Chain of 7-Azaindenoisoquinoline Topoisomerase I Inhibitors
and Mechanism of Action Studies in Cancer Cells
por: Kiselev, Evgeny, et al.
Publicado: (2014) -
Design, Synthesis, and Biological
Evaluation of O-2-Modified
Indenoisoquinolines as Dual Topoisomerase I–Tyrosyl-DNA Phosphodiesterase
I Inhibitors
por: Lv, Peng-Cheng, et al.
Publicado: (2014) -
Exploring DNA Topoisomerase I Ligand Space in Search of Novel Anticancer Agents
por: Drwal, Malgorzata N., et al.
Publicado: (2011) -
From Antarctica to cancer research: a novel human DNA topoisomerase 1B inhibitor from Antarctic sponge Dendrilla antarctica
por: Ottaviani, Alessio, et al.
Publicado: (2022) -
Synthesis and Biological Evaluation
of New Carbohydrate-Substituted
Indenoisoquinoline Topoisomerase I Inhibitors and Improved Syntheses
of the Experimental Anticancer Agents Indotecan (LMP400) and Indimitecan
(LMP776)
por: Beck, Daniel E., et al.
Publicado: (2014)